Harmony Biosciences Holdings, Inc. (HRMY)

Nasdaq Health Care Biotechnology S&P SmallCap 600

$33.11

+0.64 (+1.97%)

Close of Nov 06, 2026 · end-of-day data

Source: Harmony Biosciences Holdings, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$6.00M	$159.74M	$305.44M	$437.86M	$582.02M	$714.73M	$868.45M
Cost of revenue	$1.58M	$27.74M	$55.52M	$83.48M	$121.24M	$156.81M	$198.34M
Gross profit	$4.42M	$132.00M	$249.92M	$354.37M	$460.79M	$557.92M	$670.11M
Research & development	$69.59M	$19.45M	$30.37M	$70.89M	$76.06M	$145.82M	$189.59M
Operating income	-$145.90M	$16.99M	$87.53M	$120.19M	$192.03M	$190.83M	$208.47M
Interest expense	$7.36M	$28.61M	$24.19M	$18.80M	$23.76M	$17.50M	$14.65M
Pre-tax income	-$151.98M	-$36.94M	$37.43M	$104.69M	$173.40M	$191.80M	$215.06M
Income tax	—	—	$2.83M	-$76.78M	$44.54M	$46.31M	$56.38M
Net income	-$151.98M	-$36.94M	$34.60M	$181.47M	$128.85M	$145.49M	$158.69M
EBITDA	-$145.51M	$17.38M	$87.94M	$120.61M	$192.54M	$191.09M	—
EPS (basic)	$-24.07	$-2.48	$0.60	$3.07	$2.17	$2.56	$2.76
EPS (diluted)	$-24.07	$-2.48	$0.58	$2.97	$2.13	$2.51	$2.71
Diluted shares	7.78M	25.77M	59.21M	61.10M	60.37M	57.87M	58.54M
Gross margin	73.7%	82.6%	81.8%	80.9%	79.2%	78.1%	77.2%
Operating margin	-2433.8%	10.6%	28.7%	27.4%	33.0%	26.7%	24.0%
Net margin	-2535.1%	-23.1%	11.3%	41.4%	22.1%	20.4%	18.3%

Balance sheet

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$24.46M	$228.63M	$234.31M	$243.78M	$311.66M	$453.00M	$752.50M
Short-term investments	—	—	—	$79.33M	$41.80M	$14.19M	$22.84M
Receivables	$4.25M	$22.18M	$34.84M	$54.74M	$74.14M	$83.03M	$96.79M
Inventory	$1.09M	$3.82M	$4.43M	$4.30M	$5.36M	$7.20M	$5.36M
Total current assets	$31.50M	$262.89M	$284.44M	$400.29M	$451.07M	$579.25M	$907.01M
Total assets	$106.70M	$427.07M	$433.44M	$673.87M	$811.45M	$999.20M	$1.27B
Total current liabilities	$19.89M	$134.54M	$53.77M	$78.88M	$163.78M	$175.08M	$252.13M
Short-term debt	—	—	$2.00M	$2.00M	$15.00M	$16.25M	$20.00M
Long-term debt	$97.95M	$194.25M	$189.98M	$189.65M	$178.57M	$163.02M	$143.66M
Total debt	$97.95M	$194.25M	$191.98M	$191.65M	$193.57M	$179.27M	$163.66M
Total liabilities	$118.29M	$329.89M	$246.94M	$271.03M	$344.46M	$340.05M	$401.41M
Shareholders' equity	-$422.86M	$97.18M	$186.51M	$402.84M	$466.99M	$659.15M	$870.22M

Cash flow

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$75.44M	-$2.98M	$98.56M	$144.47M	$219.39M	$219.82M	$348.20M
Capital expenditures	$149.00K	$2.00K	$298.00K	$172.00K	$312.00K	$1.15M	$310.00K
Free cash flow	-$75.58M	-$2.99M	$98.26M	$144.29M	$219.07M	$218.67M	$347.89M
Investing cash flow	-$127.15M	-$2.00M	-$100.30M	-$141.83M	-$46.44M	-$67.48M	-$39.65M
Financing cash flow	$143.77M	$209.16M	$7.42M	$6.84M	-$105.55M	-$11.00M	-$9.05M
Share buybacks	—	$167.00K	—	—	$100.00M	—	—
Stock-based compensation	$9.91M	$4.69M	$15.66M	$26.17M	$31.70M	$42.60M	$44.90M
Depreciation & amortization	$395.00K	$394.00K	$416.00K	$419.00K	$514.00K	$267.00K	—

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$168.41M	$154.62M	$172.81M	$186.04M	$201.27M	$184.73M	$200.49M	$239.46M	$243.78M	$215.39M	$261.28M	$268.92M
Cost of revenue	$43.15M	$27.48M	$32.14M	$42.78M	$54.41M	$31.99M	$38.15M	$59.65M	$68.55M	$44.51M	$63.20M	$80.69M
Gross profit	$125.26M	$127.13M	$140.67M	$143.26M	$146.86M	$152.74M	$162.34M	$179.81M	$175.23M	$170.88M	$198.08M	$188.23M
Research & development	$30.31M	$22.19M	$63.58M	$25.39M	$34.67M	$34.54M	$50.16M	$54.96M	$49.93M	$69.38M	$46.60M	$71.66M
Operating income	$40.20M	$52.03M	$21.36M	$61.71M	$55.73M	$56.24M	$48.18M	$65.49M	$38.56M	$37.29M	$89.32M	$54.20M
Interest expense	$4.80M	$4.54M	$4.40M	$4.35M	$4.21M	$3.84M	$3.65M	$3.62M	$3.55M	$3.23M	$3.07M	$3.06M
Pre-tax income	$39.69M	$51.78M	$21.69M	$62.17M	$56.16M	$57.18M	$49.64M	$67.49M	$40.76M	$39.69M	$93.27M	$59.25M
Income tax	$13.08M	$13.45M	$10.10M	$16.08M	$6.68M	$11.62M	$9.86M	$16.62M	$18.27M	$7.20M	$17.83M	$11.05M
Net income	$26.61M	$38.33M	$11.59M	$46.09M	$49.48M	$45.56M	$39.78M	$50.87M	$22.49M	$32.49M	$75.43M	$48.20M
EBITDA	$40.36M	$52.20M	$21.45M	$61.72M	$55.73M	$56.25M	$48.19M	$65.49M	—	$37.30M	$89.32M	$54.20M
EPS (basic)	$0.46	$0.68	$0.20	$0.81	$0.87	$0.79	$0.69	$0.88	$0.40	$0.56	$1.30	$0.83
EPS (diluted)	$0.45	$0.67	$0.20	$0.79	$0.85	$0.78	$0.68	$0.87	$0.39	$0.55	$1.28	$0.81
Diluted shares	-520.60K	57.60M	57.54M	58.10M	115.90K	58.52M	58.43M	58.72M	-193.79K	58.78M	58.76M	59.68M
Gross margin	74.4%	82.2%	81.4%	77.0%	73.0%	82.7%	81.0%	75.1%	71.9%	79.3%	75.8%	70.0%
Operating margin	23.9%	33.7%	12.4%	33.2%	27.7%	30.4%	24.0%	27.3%	15.8%	17.3%	34.2%	20.2%
Net margin	15.8%	24.8%	6.7%	24.8%	24.6%	24.7%	19.8%	21.2%	9.2%	15.1%	28.9%	17.9%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$311.66M	$332.98M	$317.30M	$387.37M	$453.00M	$489.00M	$546.05M	$647.00M	$752.50M	$589.40M	$549.77M	$647.10M
Short-term investments	$41.80M	$39.37M	$29.61M	$23.11M	$14.19M	$17.95M	$19.22M	$25.58M	$22.84M	$51.52M	$118.02M	$124.04M
Receivables	$74.14M	$79.72M	$83.16M	$81.50M	$83.03M	$105.97M	$92.98M	$100.65M	$96.79M	$108.22M	$111.00M	$127.74M
Inventory	$5.36M	$5.86M	$5.64M	$6.92M	$7.20M	$6.38M	$6.10M	$6.88M	$5.36M	$5.28M	$6.36M	$5.87M
Total current assets	$451.07M	$479.50M	$458.34M	$522.40M	$579.25M	$642.69M	$691.35M	$838.80M	$907.01M	$778.82M	$814.33M	$934.83M
Total assets	$811.45M	$846.99M	$858.38M	$928.13M	$999.20M	$1.06B	$1.11B	$1.21B	$1.27B	$1.27B	$1.37B	$1.48B
Total current liabilities	$163.78M	$154.25M	$146.58M	$161.28M	$175.08M	$175.12M	$180.13M	$223.40M	$252.13M	$217.34M	$234.07M	$271.54M
Short-term debt	$15.00M	$15.00M	$15.00M	$15.00M	$16.25M	$17.50M	$18.75M	$20.00M	$20.00M	$20.00M	$20.00M	$20.00M
Long-term debt	$178.57M	$175.00M	$171.42M	$167.85M	$163.02M	$158.18M	$153.34M	$148.51M	$143.66M	$138.81M	$133.96M	$129.10M
Total debt	$193.57M	$190.00M	$186.42M	$182.85M	$179.27M	$175.68M	$172.09M	$168.51M	$163.66M	$158.81M	$153.96M	$149.10M
Total liabilities	$344.46M	$331.59M	$319.80M	$331.33M	$340.05M	$335.01M	$334.93M	$373.10M	$401.41M	$361.48M	$373.84M	$406.01M
Shareholders' equity	$466.99M	$515.39M	$538.58M	$596.80M	$659.15M	$720.52M	$773.08M	$835.12M	$870.22M	$910.35M	$999.24M	$1.07B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$76.67M	$31.14M	$42.62M	$70.50M	$75.56M	$33.99M	$79.33M	$108.73M	$126.15M	$27.76M	$92.43M	$76.69M
Capital expenditures	$107.00K	$5.00K	$632.00K	$3.00K	$513.00K	$128.00K	$4.00K	$71.00K	$107.00K	—	—	—
Free cash flow	$76.56M	$31.14M	$41.98M	$70.50M	$75.05M	$33.86M	$79.32M	$108.66M	$126.04M	$27.76M	$92.43M	$76.69M
Investing cash flow	-$36.06M	-$6.19M	-$54.86M	$745.00K	-$7.19M	$2.36M	-$19.59M	-$4.79M	-$17.63M	-$183.65M	-$131.50M	$7.68M
Financing cash flow	-$53.52M	-$3.63M	-$3.45M	-$1.18M	-$2.74M	-$352.00K	-$2.69M	-$3.00M	-$3.02M	-$7.22M	-$558.00K	$12.96M
Share buybacks	$50.00M	—	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	$8.86M	$10.39M	$11.09M	$11.05M	$10.07M	$12.50M	$11.46M	$10.97M	$9.97M	$10.62M	$9.34M	$8.05M
Depreciation & amortization	$164.00K	$163.00K	$91.00K	$7.00K	$6.00K	$7.00K	$6.00K	$7.00K	—	$7.00K	$7.00K	$7.00K

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.